Cardiac Amyloidosis Clinical Trials

Find Cardiac Amyloidosis Clinical Trials Near You

Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if a structured cardiac rehabilitation program can help people with cardiac amyloidosis improve their ability to exercise and their quality of life. The main questions it aims to answer are: Does cardiac rehabilitation raise peak oxygen uptake (VO₂ peak), which shows how well the heart and lungs work during exercise? Is cardiac rehabilitation safe and practical for people with cardiac amyloidosis? How does cardiac rehabilitation affect other exercise measures, heart function, symptoms linked to autonomic dysfunction, and quality of life? This study has no comparison group. Researchers will measure each participant's results before and after the rehabilitation program. Participants will: Complete a cardiac rehabilitation program for 5 weeks. Have tests before the program starts and again about 3 months later. These tests include: A cardiopulmonary exercise test A heart function test using electrical impedance A questionnaire about quality of life A blood sample A blood pressure test to check for orthostatic hypotension The study will include adults aged 18 or older with transthyretin cardiac amyloidosis who are able to perform an exercise test.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age 18 or older

• Cardiac ATTR amyloidosis diagnosed according to guidelines: Perugini grade II or III uptake on bone scintigraphy, without monoclonal gammopathy.

• Ability to undergo a stress test

• Available to complete the 5-week rehabilitation program within 30 days of the stress test

Locations
Other Locations
France
KRIEF
RECRUITING
Montpellier
Contact Information
Primary
Susan Martinez, PhD
s-martinezjahnke@chu-montpellier.fr
04 67 33 52 56
Backup
Johanna KRIEF, Dr
j-krief@chu-montpellier.fr
06 59 42 43 73
Time Frame
Start Date: 2026-09-23
Estimated Completion Date: 2029-09-23
Participants
Target number of participants: 40
Treatments
Experimental: Cardiac Rehabilitation Program
Participants receive a structured 5-week cardiac rehabilitation program delivered in a specialized center. The program includes two supervised sessions per day, five days per week, combining aerobic training and muscle strengthening. The rehabilitation is provided by a multidisciplinary team experienced in heart failure and functional evaluation.
Sponsors
Leads: University Hospital, Montpellier

This content was sourced from clinicaltrials.gov